NCT03940196 — Ovarian Cancer trial site landscape

Public-registry site landscape for NCT03940196, a Ovarian Cancer study sponsored by NovoCure Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT03940196 (registry record)
Sponsor	NovoCure Ltd.
Condition(s)	Ovarian Cancer
Phase	PHASE3
Listed sites	119
Site countries	United States, Austria, Belgium, Canada, Czechia, Germany, Hungary, Israel, Italy, Netherlands, Poland, Spain

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT03940196 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.